Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US CBD Hemp Oil Market

ID: MRFR/Pharma/12256-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US CBD Hemp Oil Market Research Report By Source (hemp, marijuana), By Distribution Channel (B2B, B2C, hospital pharmacies, online, retail Stores), By End User (medical, chronic pain, mental disorders, cancer) and By Personal Use (wellness, pharmaceuticals, food & beverages, personal care & Cosmetics, nutraceuticals) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US CBD Hemp Oil Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Source (USD Million)
  49.     4.1.1 Hemp
  50.     4.1.2 Marijuana
  51.   4.2 Healthcare, BY Distribution Channel (USD Million)
  52.     4.2.1 B2B
  53.     4.2.2 B2C
  54.     4.2.3 Hospital Pharmacies
  55.     4.2.4 Online
  56.     4.2.5 Retail Stores
  57.   4.3 Healthcare, BY End User (USD Million)
  58.     4.3.1 Medical
  59.     4.3.2 Chronic Pain
  60.     4.3.3 Mental Disorders
  61.     4.3.4 Cancer
  62.   4.4 Healthcare, BY Personal Use (USD Million)
  63.     4.4.1 Pharmaceuticals
  64.     4.4.2 Wellness
  65.     4.4.3 Food & Beverages
  66.     4.4.4 Personal Care & Cosmetics
  67.     4.4.5 Nutraceuticals
  68. 5 SECTION V: COMPETITIVE ANALYSIS
  69.   5.1 Competitive Landscape
  70.     5.1.1 Overview
  71.     5.1.2 Competitive Analysis
  72.     5.1.3 Market share Analysis
  73.     5.1.4 Major Growth Strategy in the Healthcare
  74.     5.1.5 Competitive Benchmarking
  75.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  76.     5.1.7 Key developments and growth strategies
  77.       5.1.7.1 New Product Launch/Service Deployment
  78.       5.1.7.2 Merger & Acquisitions
  79.       5.1.7.3 Joint Ventures
  80.     5.1.8 Major Players Financial Matrix
  81.       5.1.8.1 Sales and Operating Income
  82.       5.1.8.2 Major Players R&D Expenditure. 2023
  83.   5.2 Company Profiles
  84.     5.2.1 Charlotte's Web (US)
  85.       5.2.1.1 Financial Overview
  86.       5.2.1.2 Products Offered
  87.       5.2.1.3 Key Developments
  88.       5.2.1.4 SWOT Analysis
  89.       5.2.1.5 Key Strategies
  90.     5.2.2 CV Sciences (US)
  91.       5.2.2.1 Financial Overview
  92.       5.2.2.2 Products Offered
  93.       5.2.2.3 Key Developments
  94.       5.2.2.4 SWOT Analysis
  95.       5.2.2.5 Key Strategies
  96.     5.2.3 Green Roads (US)
  97.       5.2.3.1 Financial Overview
  98.       5.2.3.2 Products Offered
  99.       5.2.3.3 Key Developments
  100.       5.2.3.4 SWOT Analysis
  101.       5.2.3.5 Key Strategies
  102.     5.2.4 Medterra (US)
  103.       5.2.4.1 Financial Overview
  104.       5.2.4.2 Products Offered
  105.       5.2.4.3 Key Developments
  106.       5.2.4.4 SWOT Analysis
  107.       5.2.4.5 Key Strategies
  108.     5.2.5 Hemp Bombs (US)
  109.       5.2.5.1 Financial Overview
  110.       5.2.5.2 Products Offered
  111.       5.2.5.3 Key Developments
  112.       5.2.5.4 SWOT Analysis
  113.       5.2.5.5 Key Strategies
  114.     5.2.6 Pure Spectrum (US)
  115.       5.2.6.1 Financial Overview
  116.       5.2.6.2 Products Offered
  117.       5.2.6.3 Key Developments
  118.       5.2.6.4 SWOT Analysis
  119.       5.2.6.5 Key Strategies
  120.     5.2.7 Joy Organics (US)
  121.       5.2.7.1 Financial Overview
  122.       5.2.7.2 Products Offered
  123.       5.2.7.3 Key Developments
  124.       5.2.7.4 SWOT Analysis
  125.       5.2.7.5 Key Strategies
  126.     5.2.8 Elixinol (AU)
  127.       5.2.8.1 Financial Overview
  128.       5.2.8.2 Products Offered
  129.       5.2.8.3 Key Developments
  130.       5.2.8.4 SWOT Analysis
  131.       5.2.8.5 Key Strategies
  132.   5.3 Appendix
  133.     5.3.1 References
  134.     5.3.2 Related Reports
  135. 6 LIST OF FIGURES
  136.   6.1 MARKET SYNOPSIS
  137.   6.2 US MARKET ANALYSIS BY SOURCE
  138.   6.3 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  139.   6.4 US MARKET ANALYSIS BY END USER
  140.   6.5 US MARKET ANALYSIS BY PERSONAL USE
  141.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  142.   6.7 RESEARCH PROCESS OF MRFR
  143.   6.8 DRO ANALYSIS OF HEALTHCARE
  144.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  145.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  146.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  147.   6.12 HEALTHCARE, BY SOURCE, 2024 (% SHARE)
  148.   6.13 HEALTHCARE, BY SOURCE, 2024 TO 2035 (USD Million)
  149.   6.14 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  150.   6.15 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  151.   6.16 HEALTHCARE, BY END USER, 2024 (% SHARE)
  152.   6.17 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
  153.   6.18 HEALTHCARE, BY PERSONAL USE, 2024 (% SHARE)
  154.   6.19 HEALTHCARE, BY PERSONAL USE, 2024 TO 2035 (USD Million)
  155.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  156. 7 LIST OF TABLES
  157.   7.1 LIST OF ASSUMPTIONS
  158.     7.1.1
  159.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  160.     7.2.1 BY SOURCE, 2025-2035 (USD Million)
  161.     7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  162.     7.2.3 BY END USER, 2025-2035 (USD Million)
  163.     7.2.4 BY PERSONAL USE, 2025-2035 (USD Million)
  164.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  165.     7.3.1
  166.   7.4 ACQUISITION/PARTNERSHIP
  167.     7.4.1

US Healthcare Market Segmentation

Healthcare By Source (USD Million, 2025-2035)

  • Hemp
  • Marijuana

Healthcare By Distribution Channel (USD Million, 2025-2035)

  • B2B
  • B2C
  • Hospital Pharmacies
  • Online
  • Retail Stores

Healthcare By End User (USD Million, 2025-2035)

  • Medical
  • Chronic Pain
  • Mental Disorders
  • Cancer

Healthcare By Personal Use (USD Million, 2025-2035)

  • Pharmaceuticals
  • Wellness
  • Food & Beverages
  • Personal Care & Cosmetics
  • Nutraceuticals

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions